Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage…

By W. Hiddemann, Michael Kneba, M. Dreyling, Norbert Schmitz, Eva Lengfelder, R. Schmits, M. Reiser, B. Metzner, H. Harder, S. Hegewisch-Becker and 13 more. Blood, 2005

724 citations recorded by the source corpus.

Subfields: Immunology, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/181d8ccaee5a3919341159e7d380385899b98213

Citations in the corpus

• Follicular lymphoma international prognostic index (2006, background): “A large randomized trial of FL patients treated with six cycles of CHOP with or without rituximab has been recently published [ 15 ].”